Live AstraZeneca updates

Live AstraZeneca news coverage of developments with the latest updates. Stay on top of latest AstraZeneca news stories and find out what just happened, what is going on with AstraZeneca. The latest real-time news updates and headlines on AstraZeneca
EU Recommends Datroway for 1st-Line Breast Cancer Use
Cambridge South Station Opens
KI, Stockholm School Boost Global Health Leaders
Karolinska, SSE Boost Global Health Leaders
ERC Awards KI Researchers for Cancer, Inflammation Cures
Digital Health Tools Transform U.S. Healthcare
9 OMP Customers on 2026 Gartner Top 25 List
TGA Product Information Safety Updates 15 June
Ultomiris Gets US Priority Review for IgA Nephropathy
US OKs Truqap as First PTEN-deficient Prostate Drug
AI Accelerates Molecular Simulations 10,000-Fold
AI Model Boosts Liquid Biopsy Accuracy
Elecoglipron Advances to Phase III in AstraZeneca Trials
GLP-1 Pill Cuts Blood Sugar, Trims Bodyweight
Diabetes Drug Cuts Heart Failure in Genetic Risk Group
Ultomiris Cuts Proteinuria 43% in IgA Nephropathy Trial
Trio of New Ebola Vaccines in Development
Super-fit Show Lower Irregular Heartbeat Risk
Low-Dose Zoladex Unavailable in Australia from Nov
Pain Cant Be Measured by Lie Detector: Heres Why
FORTIFY Launches to Boost EU Health Data Innovation
Research: 1 in 10 High-Risk May Have Hidden Heart Attack
Camizestrant Combo Slows Breast Cancer Progression
Imfinzi Combo Cuts Liver Cancer Risk by 30% in Trial
CARES Phase III Misses Main Goal, Shows Promise for Anselamimab
Imfinzi Wins U.S. Nod for Unique Bladder Cancer Combo
MIT Elects 10 Term, 2 Life Members for 2026
FDA Extends Review for SERENA-6 Camizestrant Data
Datroway Gets US Nod as First-Line Drug for Metastatic TNBC
CHMP Backs Enhertu Approval for HER2+ Metastatic Tumors
CHMP Backs Camizestrant Combo for Advanced Breast Cancer
AstraZeneca Unveils Phase III Cancer, Rare Disease Data
Andexxa Registration Lapses for Factor Xa Reversal
New Plans Advance Rare Disease Treatments
Research: BMI Fails to Capture Full Obesity Health Risks
UK's Largest Business Delegation Launches in LA
UK Drug Shortages Persist, Supply Chain Fixes Insufficient
FDA Clears Enhertu for Two New HER2+ Cancer Uses
Imfinzi Combo Boosts Survival in Bladder Cancer Trial
Eneboparatide Boosts Calcium in Hypoparathyroidism Trial
Research Unveils Better Diagnosis for Missed Heart Condition
Cambridge South Station Opening Date Announced
Needle-Free Flu Vaccine Targets Kids' Immunity Boost
Gut Hormone FGF15 Alters Mice's Weight Loss Response
UK's Biggest Trade Mission Heads to LA
FDA Panel Recommends Truqap for PTEN-Deficient Prostate Cancer
FDA Panel Votes on Camizestrant Combo for HR+ Breast Cancer
New Tool Predicts Genetic Risk for 8 Heart Conditions